What Peptide–HLA Binding and Stability Assay Services Cover
Peptide–HLA binding and stability assay services assess whether candidate peptides associate with a selected HLA allele and how stable the resulting complex is under defined assay conditions. Projects typically combine a binding assessment with a stability readout so that candidate peptides can be ranked before downstream cell-based or functional work. Peptides can be supplied by the client or arranged through a peptide synthesis step when the project requires it. Assay format, HLA allele coverage, peptide panel size, and the depth of stability testing are defined case by case in the project scope, and results are reported as assay-level readouts for comparative evaluation rather than as a prediction of clinical or functional outcome.
Candidate prioritization can be followed by dendritic cell maturation and antigen presentation assays to investigate presentation in a cellular system.
What the Service Can Include
Binding Assessment
Candidate peptides are tested against the selected HLA allele in a binding assay, with relative binding readouts reported for comparison across the peptide panel.
Complex Stability Evaluation
Selected peptides can be carried into a stability assessment to compare how well the peptide–HLA complex holds up under the defined assay conditions.
Peptide Sourcing Support
Peptides may be provided by the client or arranged through peptide synthesis when the project scope calls for it, so panel design and assay setup stay aligned.
Panel Ranking and Reporting
Results are summarized so candidate peptides can be ranked within the tested panel, with assay conditions and any project-scoped follow-up options documented in the report.
How a Typical Project Runs
Project Deliverables
| Deliverable | What You Receive |
|---|---|
| Binding assay report | A structured report summarizing peptide–HLA binding results for each candidate tested, with the assay conditions and controls documented so the data can be reviewed and reproduced. |
| Stability and half-life readouts | Assay-level stability data for the peptide–HLA complexes evaluated, reported per candidate and per condition as defined in the project scope. |
| Candidate ranking table | A comparative summary that places tested peptides side by side on the measured binding and stability readouts, supporting selection of candidates for follow-up work. |
| Peptide sourcing record | Documentation of whether peptides were client-supplied or synthesized when included in project scope, including peptide identity and handling information recorded during the project. |
| QC and methods summary | A concise methods and quality-control summary covering assay setup, controls, and acceptance criteria applied to the run. |
Why Choose Our Peptide–HLA Binding and stability Assay Service
Flexible peptide sourcing
Peptides for the assay can be provided by your team or synthesized when included in project scope, so projects can start from an existing candidate set or from a designed panel. Sourcing is agreed during scoping.
Binding plus stability in one engagement
The service combines peptide–HLA binding assessment with stability evaluation, giving a more complete view of each candidate than a single readout alone. The exact readouts and conditions are defined per project.
Candidate-focused reporting
Results are organized around the candidates you need to compare, with ranking tables and per-candidate readouts that support go/no-go decisions. Follow-up validation options can be discussed when scoped.
Further Reading
Research reference
1. Systematic discovery of neoepitope–HLA pairs for neoantigens shared among patients and tumor types
Nature Biotechnology. 2024. DOI: 10.1038/s41587-023-01945-y.
View articleStart a Peptide–HLA Binding and Stability Assay Project
Share your candidate peptides, HLA allele context, and the decision you need to support. We will confirm assay format, peptide sourcing, controls, and reporting scope before work begins, so the study matches your epitope-selection or immunogenicity program.
An integrated follow-up plan can include antigen-specific T cell response assays for candidates selected from the binding and stability panel.